Pro Medicus Stock

Pro Medicus EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Pro Medicus (PME.AX) as of Aug 7, 2026 is 79.22. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 111.30 — a change of -28.82% (lower).

EV/EBIT

79.22

YoY

-28.82%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Pro Medicus is 2026 79.22 . EV/EBIT (Enterprise Value to EBIT) of Pro Medicus was 2025 111.30 . It decreases by -28.82% lower compared to the previous year.

The Pro Medicus EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
90.77 base
Jan 1, 2020
118.01 base
Jan 1, 2021
153.19 base
Jan 1, 2022
93.27 base
Jan 1, 2023
115.85 base
Jan 1, 2024
222.54 base
Jan 1, 2025
139.89 base
Jan 1, 2026 (e)
85.43 base
YEARPRICE-TO-EBIT
2026 est 85.43
2025 139.89
2024 222.54
2023 115.85
2022 93.27
2021 153.19
2020 118.01
2019 90.77
2018 76.47
2017 63.99
2016 50.76
2015 99.14
2014 43.02
2013 -70.89
2012 198.13
2011 20.06
2010 10.78
2009 14.19
2008 8.78
2007 14.65
2006 15.90
Access this data via the Eulerpool API
Get Free API Key

Pro Medicus Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Pro Medicus's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Pro Medicus's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Pro Medicus's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Pro Medicus grows earnings faster than its peers.

Pro Medicus Stock analysis

What does Pro Medicus do? Pro Medicus Ltd. is an Australian company specializing in the development and distribution of medical imaging software solutions. The company was founded in 1983 and is headquartered in Melbourne. Pro Medicus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pro Medicus stock

EV/EBIT (Enterprise Value to EBIT) of Pro Medicus is 79.22 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Pro Medicus changed from 111.30 to 79.22, representing a -28.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Pro Medicus since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Pro Medicus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Pro Medicus

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Pro Medicus